{"version":"1.0","provider_name":"Simtra BioPharma Solutions","provider_url":"https:\/\/simtra.com\/de\/","author_name":"dunnco","author_url":"https:\/\/simtra.com\/de\/author\/dunnco\/","title":"Lyophilization Development for Antibody-Drug Conjugates (ADCs) &#8212; Simtra BioPharma Solutions","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"HOkCE6PBWM\"><a href=\"https:\/\/simtra.com\/de\/resource\/lyophilization-development-for-antibody-drug-conjugates-adcs\/\">Lyophilization Development for Antibody-Drug Conjugates (ADCs)<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/simtra.com\/de\/resource\/lyophilization-development-for-antibody-drug-conjugates-adcs\/embed\/#?secret=HOkCE6PBWM\" width=\"600\" height=\"338\" title=\"&#8220;Lyophilization Development for Antibody-Drug Conjugates (ADCs)&#8221; &#8212; Simtra BioPharma Solutions\" data-secret=\"HOkCE6PBWM\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\" nonce=\"7418b5ae9e7c4247de56530bb2eb1c87c14c15eee5a3e0a5cfb64dde10e5133774ef712b4dcc5fed31e64e8c1b2bb5160fe500aa3de9d435eed2ffb6ad045450\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/simtra.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"With their ability to deliver precisely targeted therapies for a growing number of cancer types, it\u2019s no wonder that the development and approval of ADCs is expanding, with 21 now approved worldwide and more than 350 in clinical development. Because the antibody is generally less stable than the small-molecule cytotoxic agent, 90% of commercially available..."}